Skip to main content
. 2022 Oct 24;13:977117. doi: 10.3389/fimmu.2022.977117

Table 1.

Patient characteristic.

No Age M/F Location Clinical stage Operation
control 1 colon cancer 48 F AC T3N0M0 ilio-cecal sectomy
5 colon cancer 85 F AC T3N1M0 ilio-cecal sectomy
7 colon cancer 42 M AC T1N0M0 ilio-cecal sectomy
9 colon cancer 60 F AC T3N0M0 ilio-cecal sectomy
11 colon cancer 80 M AC T1N0M0 ilio-cecal sectomy
22 colon cancer 63 M AC T3N0M0 ilio-cecal sectomy
23 colon cancer 67 F AC T4N0M0 ilio-cecal sectomy
52 colon cancer 68 F AC T2N1M0 ilio-cecal sectomy
54 colon cancer 81 M AC T3N2M0 ilio-cecal sectomy
No CD/UC Age M/F Disease status/active Disease Type Operation
IBD 6 CD 54 F stenosis. Active disease intestinal type ileum resection
7 CD 25 F active ulcer intestinal type ileum resection
8 CD 40 M stenosis. Active disease colon-intestinal ileum resection
15 CD 40 M stenosis. Active disease colon intestinal ileum resection
17 CD 37 F stenosis. Active disease colon intestinal ileum resection
22 CD 29 M stenosis. Active disease colon intestinal ileum resection
23 CD 53 M stenosis. Active disease colon intestinal ileum resection
9 UC 27 M UC active pan colitis colon resection

AC, Ascending colon.

Single cell analysis: HD-No.52,54

Single cell analysis: IBD-No.7,9